MedPath

CELGENE PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

HSA:10

Drug Approvals

POMALYST CAPSULE 3MG

Approval Date
Dec 30, 2014
HSA

POMALYST CAPSULE 1MG

Approval Date
Dec 30, 2014
HSA

POMALYST CAPSULE 4MG

Approval Date
Dec 30, 2014
HSA

POMALYST CAPSULE 2MG

Approval Date
Dec 30, 2014
HSA

ABRAXANE FOR INJECTABLE SUSPENSION 100mg/vial

Approval Date
Mar 31, 2014
HSA

Vidaza powder for suspension for injection 100mg/vial

Approval Date
May 18, 2010
HSA

Revlimid Capsules 15 mg

Approval Date
Jun 23, 2009
HSA

Revlimid Capsules 5mg

Approval Date
Jun 23, 2009
HSA

Revlimid Capsules 10mg

Approval Date
Jun 23, 2009
HSA

Revlimid Capsules 25 mg

Approval Date
Jun 23, 2009
HSA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.